Our goal is to prevent cancer, extend survival rates, and improve quality of life for people with cancer Sentrimed is currently refining the production of drugs that specifically target malignant and metastatic cancer cells. This technology should fight the disease without the toxicity and collateral damage produced by conventional chemotherapy drugs. Copyright 2018 Sentrimed | All Rights Reserved. Sentrimed® and MASL® are registered trademarks of Sentrimed.
View Top Employees from Sentrimed| Website | http://www.sentrimed.org |
| Revenue | $4 million |
| Employees | 1 (1 on RocketReach) |
| Address | 107 Gilbreth Pkwy, Mullica Hill, New Jersey 08062, US |
| Phone | (856) 651-7140 |
| Industry | Business Services General, Business Services |
| Competitors | Cancer Research Center, JOHN PAUL II MEDICAL RESEARCH INSTITUTE |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Sentrimed employee's phone or email?
Sentrimed Questions
The Sentrimed annual revenue was $4 million in 2023.
1 people are employed at Sentrimed.
Sentrimed is based in Mullica Hill, New Jersey.
The NAICS codes for Sentrimed are [54, 541, 5417].
The SIC codes for Sentrimed are [873, 87].
